These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35174182)

  • 21. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of polypoidal choroidal vasculopathy with and without hemorrhage treated by anti-VEGF monotherapy.
    Iwasaki M; Kobayashi K; Aoki S; Miyamoto H; Imaizumi H
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1741-1750. PubMed ID: 33409679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Shen YS; Cheng CK
    Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Chang YC; Cheng CK
    Retina; 2020 Jul; 40(7):1403-1411. PubMed ID: 31181038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.
    Yannuzzi LA; Wong DW; Sforzolini BS; Goldbaum M; Tang KC; Spaide RF; Freund KB; Slakter JS; Guyer DR; Sorenson JA; Fisher Y; Maberley D; Orlock DA
    Arch Ophthalmol; 1999 Nov; 117(11):1503-10. PubMed ID: 10565519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study.
    Yang J; Yuan M; Wang E; Xia S; Chen Y
    BMC Ophthalmol; 2019 Nov; 19(1):237. PubMed ID: 31752769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY; Choi M; Chung B; Byeon SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicolour imaging for the detection of polypoidal choroidal vasculopathy and age-related macular degeneration.
    Tan CS; Ting DS; Lim LW
    Clin Exp Ophthalmol; 2019 Jul; 47(5):621-630. PubMed ID: 30578655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration.
    Lorentzen TD; Subhi Y; Sørensen TL
    Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy.
    Tanaka K; Nakayama T; Mori R; Sato N; Kawamura A; Yuzawa M
    BMC Ophthalmol; 2014 Jun; 14():83. PubMed ID: 24965207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy.
    Tan CS; Ngo WK; Lim LW; Tan NW; Lim TH
    Clin Exp Ophthalmol; 2019 Jul; 47(5):614-620. PubMed ID: 30652395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundus autofluorescence in polypoidal choroidal vasculopathy.
    Yamagishi T; Koizumi H; Yamazaki T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1650-7. PubMed ID: 22512987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Trends in Clinical Characteristics, Diagnosis, and Treatment of Polypoidal Choroidal Vasculopathy: A Perspective from Vietnam.
    Dat DT; Hien NDTN; Quan NN; Tung MQ; Tam HC; Hung BV
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polypoidal Choroidal Vasculopathy.
    Kim JB; Nirwan RS; Kuriyan AE
    Curr Ophthalmol Rep; 2017 Jun; 5(2):176-186. PubMed ID: 29276655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of subfoveal choroidal structures in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Takahashi Y; Koizumi H; Hasegawa T; Izumi T; Maruko I; Sonoda S; Sakamoto T; Iida T
    Jpn J Ophthalmol; 2018 Sep; 62(5):576-583. PubMed ID: 30069649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
    Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
    Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacement of polyps with type 1 macular neovascularization in polypoidal choroidal vasculopathy imaged with swept source OCT angiography.
    Shen M; Bo Q; Song M; Jiang X; Yehoshua Z; Gregori G; Sun X; Wang F; Rosenfeld PJ
    Am J Ophthalmol Case Rep; 2021 Jun; 22():101057. PubMed ID: 33796797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T
    Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
    Cheung CMG; Lai TYY; Ruamviboonsuk P; Chen SJ; Chen Y; Freund KB; Gomi F; Koh AH; Lee WK; Wong TY
    Ophthalmology; 2018 May; 125(5):708-724. PubMed ID: 29331556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.